Skip to main content

Table 2 Synthetic Peptides, second vaccination and immunomonitoring

From: A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer

IDAmino acid sequenceHLA-restrictionSource protein, HLA-restrictionAA position within source protein
CMV-VPAPVTEHDTLLYHLA-A*01Human cytomegalovirus, DNA polymerase processivity factor (hCMV, VPAP)245–253
CMV-pp65YSEHPTFTSQYHLA-A*01Human cytomegalovirus, 65 kDa phosphoprotein (hCMV, pp65)363–373
CMV-VIE1ELRRKMMYMHLA-B*08Human cytomegalovirus, 55 kDa immediate-early protein 1 (hCMV, VIE1)199–207
EBV-GP350PRPVSRFLGNNSILYHLA-DREpstein-Barr virus, Envelope Glycoprotein GP350 (EBV, gp350)268–282
CMV-pp65283–299KPGKISHIMLDVAFTSHHLA-DRHuman cytomegalovirus, 65 kDa phosphoprotein (hCMV, pp65)283–299
CMV-pp65510–524YQEFFWDANDIYRIFHLA-DRHuman cytomegalovirus, 65 kDa phosphoprotein (hCMV, pp65)510–524